LISATA THERAPEUTICS, INC. Proceeds from Divestiture of Businesses
LISATA THERAPEUTICS, INC. (LSTA) reported Proceeds from Divestiture of Businesses of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromDivestitureOfBusinesses · last filed 2019-03-14
- LISATA THERAPEUTICS, INC. proceeds from divestiture of businesses for the quarter ending 2018-12-31 was $0.00.
- LISATA THERAPEUTICS, INC. proceeds from divestiture of businesses for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. proceeds from divestiture of businesses for the quarter ending 2017-12-31 was -$82.81K.
- LISATA THERAPEUTICS, INC. proceeds from divestiture of businesses for the quarter ending 2017-09-30 was $4.43M.
- LISATA THERAPEUTICS, INC. proceeds from divestiture of businesses for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- LISATA THERAPEUTICS, INC. proceeds from divestiture of businesses for fiscal 2017 was $74.61M.
- LISATA THERAPEUTICS, INC. proceeds from divestiture of businesses for fiscal 2016 was $0.00.
- LISATA THERAPEUTICS, INC. proceeds from divestiture of businesses for fiscal 2014 was $0.00.
| Period end | Proceeds from Divestiture of Businesses 3 month | Proceeds from Divestiture of Businesses 6 month | Proceeds from Divestiture of Businesses 9 month | Proceeds from Divestiture of Businesses 12 month | Proceeds from Divestiture of Businesses 12 month as first filed |
|---|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $0.00 derived: sum of 2 quarters · filed 2019-03-14 | $0.00 10-K · filed 2019-03-14 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $0.00 10-Q · filed 2018-11-08 | |||
| 2018-06-30 | $0.00 10-Q · filed 2018-08-09 | ||||
| 2017-12-31 | -$82.81K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $4.34M derived: sum of 2 quarters · filed 2019-03-14 | $74.61M 10-K · filed 2019-03-14 | $74.61M 10-K · filed 2018-03-22 | |
| 2017-09-30 | $4.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $74.69M 10-Q · filed 2018-11-08 | |||
| 2017-06-30 | $70.26M 10-Q · filed 2018-08-09 | ||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $0.00 derived: sum of 2 quarters · filed 2018-03-22 | $0.00 10-K · filed 2018-03-22 | ||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $0.00 10-Q · filed 2017-11-09 | |||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-10 | ||||
| 2014-12-31 | $0.00 10-K · filed 2015-03-02 | ||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $0.00 10-K · filed 2015-03-02 | |||
| 2013-09-30 | $0.00 10-Q · filed 2013-11-07 | ||||
| 2012-12-31 | $9.55M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $12.28M 10-K · filed 2015-03-02 | |||
| 2012-09-30 | $2.73M 10-Q · filed 2013-11-07 | ||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | $0.00 10-K · filed 2013-03-11 | |||
| 2011-09-30 | $0.00 10-Q · filed 2012-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |